These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 17631710

  • 21. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL.
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [Abstract] [Full Text] [Related]

  • 22. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH, Sheppard BC, Schwartz J, Orloff SL.
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [Abstract] [Full Text] [Related]

  • 23. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system.
    Yu JW, Wang GQ, Li SC.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1519-24. PubMed ID: 16928211
    [Abstract] [Full Text] [Related]

  • 24. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH, Kim YS, Jang JY, Cheon YG, Kim YS, Cho YD, Lee JS, Lee MS, Kim JH, Shim CS, Kim BS.
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [Abstract] [Full Text] [Related]

  • 25. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S, Ghani H, Memon S, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [Abstract] [Full Text] [Related]

  • 26. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 27. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P, Desai N, Alexander J, Singh DP, Sawant P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 34. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 35. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H, Wang H, Sun Y, Guo F, Fang JL, Shao J, Rao HY, Wang J, Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [Abstract] [Full Text] [Related]

  • 36. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 37. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.